Form 6-K BRENX LTD. For: Aug 13
http://archive.fast-edgar.com/20260813/AP22T62CLZ22FZ5Z2IZB2ZY2KN8RC222Z28G
Filed on: August 13, 2026
Form SCHEDULE 13G Chemomab Therapeutics Filed by: Touchstone Global Investments Pty Ltd
html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td
{
margin: 0;
padding: 0;
border: 0;
outline: 0;
font-weight: inherit;
font-style: inherit;
font-size: 100%;
font-family: inherit;
vertical-align:... (continue reading...)
Form 6-K Suzano S.A. For: Jun 30
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, DC 20549FORM 6-KREPORT OF FOREIGN PRIVATE ISSUERPURSUANT TO RULE 13a-16 OR 15d-16UNDER THE SECURITIES EXCHANGE ACT OF 1934For the month of June, 2026.Commission File Number 001-38755Suzano S.A.(Exact name of registrant as specified in its charter)SUZANO INC. (Translation of Registrant’s Name into English)Av. Professor Magalhaes Neto, 1,75210th Floor, Rooms 1010 and 1011Salvador, Brazil 41 810-012(Address of... (continue reading...)
Form 8-K PDS Biotechnology Corp For: Aug 13
false0001472091NASDAQ00014720912026-08-132026-08-13
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 13, 2026
PDS BIOTECHNOLOGY CORPORATION
(Exact Name... (continue reading...)
More SEC Filings
View Older Stories-
Form 10-Q SPAR Group, Inc. For: Jun 30
-
Form 13F-HR Carmignac Gestion For: Jun 30
-
Form 10-Q FATE THERAPEUTICS INC For: Jun 30
-
Form 10-Q Ovid Therapeutics Inc. For: Jun 30
-
Form 13F-HR Dixon Mitchell Investmen For: Jun 30
-
Form 13F-HR Sandhill Capital Partner For: Jun 30
-
Form 10-Q HeartCore Enterprises, For: Jun 30
-
Form 8-K Ovid Therapeutics Inc. For: Aug 11
-
Form 8-K FATE THERAPEUTICS INC For: Aug 13
-
Form 10-Q Nakamoto Inc. For: Jun 30
-
Form 10-Q Caring Brands, Inc. For: Jun 30
-
Form 10-Q Candel Therapeutics, For: Jun 30
-
Form 10-Q K2 Capital Acquisition For: Jun 30
-
Form 10-Q DUKE Robotics Corp. For: Jun 30
-
Form 8-K HeartCore Enterprises, For: Aug 13
-
Form 8-K Tron Inc. For: Aug 13
-
Form 8-K SS Innovations Internati For: Aug 13
-
Form 8-K FITLIFE BRANDS, INC. For: Aug 11
-
Form SCHEDULE 13G Research Alliance Corp Filed by: Spruce Street Capital LP
-
Form 6-K Eco Wave Power Global For: Aug 13
-
Form N-PX Pillsbury Lake Capital For: Jun 30
-
Form D/A lmpactA Global Partners
-
Form 8-K Banzai International, For: Aug 13
-
Form 497 JACKSON NATIONAL SEPARAT
-
Form 497 JACKSON NATIONAL SEPARAT
-
Form 497 JACKSON NATIONAL SEPARAT
-
Form 497 JACKSON NATIONAL SEPARAT
-
Form 8-K Ondas Inc. For: Aug 13
-
Form 6-K DEFSEC Technologies Inc. For: Aug 13
-
Form N-PX Varenne Capital Partners For: Jun 30
-
Form 13F-HR Mount Capital Ltd For: Jun 30
-
Form 8-K SONIDA SENIOR LIVING, For: Aug 07
-
Form 4 Cellebrite DI Ltd. For: Aug 12 Filed by: Jewell Marcus
-
Form 13F-HR Crestview Partners IV For: Jun 30
-
Form 8-K Lucid Diagnostics Inc. For: Aug 13
-
Form 10-Q MeiraGTx Holdings plc For: Jun 30
-
Form 13F-HR Crestview Partners III For: Jun 30
-
Form 13F-HR BOWEN HANES & CO INC For: Jun 30
-
Form 144/A CAMTEK LTD Filed by: Eisenberg Moshe
-
Form 13F-HR Crestview Partners II For: Jun 30
-
Form 10-Q NEUROONE MEDICAL TECHNOL For: Jun 30
-
Form 13F-HR Langdon Equity Partners For: Jun 30
-
Form 10-Q National Vision Holdings For: Jul 04
-
Form 10-Q Solo Brands, Inc. For: Jun 30
-
Form 10-Q Pulmatrix, Inc. For: Jun 30
-
Form 13F-HR Yakira Capital Managemen For: Jun 30
-
Form 13F-HR Sienna Gestion For: Jun 30
-
Form 10-Q Yesway, Inc. For: Jun 30
-
Form 10-Q SS Innovations Internati For: Jun 30
-
Form 6-K GDS Holdings Ltd For: Aug 13
